Therapeutic Options to Further Lower C-Reactive Protein for Patients on Statin Treatment
Author:
Publisher
Springer Science and Business Media LLC
Subject
Cardiology and Cardiovascular Medicine
Link
http://link.springer.com/content/pdf/10.1007/s11883-009-0075-x.pdf
Reference37 articles.
1. Ridker P: C-reactive protein: eighty years from discovery to emergence as a major risk marker for cardiovascular disease. Clin Chem 2009, 55:209–215.
2. Ledue TB, Rifai N: High sensitivity immunoassays for C-reactive protein: promises and pitfalls. Clin Chem Lab Med 2001, 39:1171–1176.
3. Roberts WL, Moulton L, Law TC, et al.: Evaluation of nine automated high-sensitivity C-reactive protein methods: implications for clinical and epidemiological applications. Part 2. Clin Chem 2001, 47:418–425.
4. Sachdeva A, Cannon C, Deedwania P, et al.: Lipid levels in patients hospitalized with coronary artery disease: an analysis of 136,905 hospitalizations in Get with the Guidelines. Am Heart J 2009, 157:111–117.
5. •• Ridker PM, Danielson E, Fonseca FA, et al.: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Eng J Med 2008, 359:2195–2207. The landmark JUPITER trial was a prospective, randomized controlled trial that evaluated the use of statin therapy in patients considered to have cholesterol levels at target by current guidelines and elevated hsCRP greater than 2.0. The trial was stopped early due to the large risk reduction in the treatment group.
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Current and future options in cholesterol lowering treatments;European Journal of Internal Medicine;2023-06
2. Cholesterol-Lowering Drugs on Akt Signaling for Prevention of Tumorigenesis;Frontiers in Genetics;2021-09-16
3. The Effect of Statins on C-Reactive Protein in Stroke Patients: A Systematic Review of Clinical Trials;Mediators of Inflammation;2021-08-27
4. Effect of Antihypertensive and Statin Medication Use on Muscle Performance in Community-Dwelling Older Adults Performing Strength Training;Drugs & Aging;2021-02-05
5. Urotensin-II, oxidative stress, and inflammation increase in hypertensive and resistant hypertensive patients;Clinical and Experimental Hypertension;2020-11-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3